Fulgent Genetics, Inc. (FLGT)
21.48
+0.18
(+0.85%)
USD |
NASDAQ |
Oct 02, 16:00
21.50
+0.02
(+0.09%)
After-Hours: 20:00
Fulgent Genetics Profit Margin (Quarterly) : -34.80% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -34.80% |
| March 31, 2026 | -35.53% |
| December 31, 2025 | -28.38% |
| September 30, 2025 | -8.12% |
| June 30, 2025 | -23.54% |
| March 31, 2025 | -16.20% |
| December 31, 2024 | -8.12% |
| September 30, 2024 | -20.48% |
| June 30, 2024 | -12.80% |
| March 31, 2024 | -21.47% |
| December 31, 2023 | -190.5% |
| September 30, 2023 | -15.90% |
| June 30, 2023 | -17.08% |
| March 31, 2023 | -23.95% |
| December 31, 2022 | -35.56% |
| September 30, 2022 | 1.27% |
| June 30, 2022 | 8.86% |
| March 31, 2022 | 47.95% |
| December 31, 2021 | 41.20% |
| September 30, 2021 | 53.64% |
| June 30, 2021 | 49.42% |
| March 31, 2021 | 55.84% |
| Date | Value |
|---|---|
| December 31, 2020 | 56.98% |
| September 30, 2020 | 45.85% |
| June 30, 2020 | 19.24% |
| March 31, 2020 | -25.23% |
| December 31, 2019 | -3.53% |
| September 30, 2019 | 14.13% |
| June 30, 2019 | 3.93% |
| March 31, 2019 | -35.53% |
| December 31, 2018 | -36.19% |
| September 30, 2018 | -10.58% |
| June 30, 2018 | -19.43% |
| March 31, 2018 | -41.05% |
| December 31, 2017 | -41.46% |
| September 30, 2017 | -24.27% |
| June 30, 2017 | -0.54% |
| March 31, 2017 | 4.37% |
| December 31, 2016 | 13.89% |
| September 30, 2016 | -22.09% |
| June 30, 2016 | -113.1% |
| March 31, 2016 | -17.50% |
| December 31, 2015 | -252.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 10.94% |
| Labcorp Holdings, Inc. | 8.02% |
| OPKO Health, Inc. | -5.14% |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 1.11% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.94% |
| Return on Assets | -7.28% |
| Return on Invested Capital | -7.88% |
| Gross Profit Margin (Quarterly) | 27.02% |
| Operating Margin (Quarterly) | -39.39% |
| Return on Net Operating Assets | -17.93% |